ESPR
Esperion Therapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Jul 15, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -113.4% | – | – | – | – | – | – | -161.3% | – | |
| – | -49.0% | -76.9% | +7,183.3% | -97.7% | -4,210.0% | – | +2,585.2% | -96.3% | -3.7% | +5,376.9% | -98.1% | – | |
| – | -5.9% | -1.8% | +10.8% | -9.4% | +3.1% | -7.2% | -12.1% | +8.3% | -12.0% | +1.6% | +4.8% | – | |
| – | +371.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -35.2% | -39.9% | -651.3% | – | – | – | – | -318.8% | – | -201.7% | – | – | |
| – | – | – | – | +5.5% | +116.9% | -100.0% | – | – | – | – | +0.0% | – | |
| – | – | – | – | +5.5% | +116.9% | – | – | – | – | – | -200.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -633.0% | – | +1,926.5% | -133.1% | -69.7% | – | -121.4% | – | +274.5% | +182.6% | -46.2% | – | |
| – | – | – | – | -125.8% | – | – | -68,572.7% | – | – | +1,080.8% | -115.5% | – | |
| – | – | – | – | -113.5% | – | – | – | – | – | – | -161.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.